PATH
Menu

Filter browse results

Total results with these characteristics: 747

Region: Global

Protecting Aluminum-Adjuvanted Vaccines From Freeze Damage

This overview describes how PATH has developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global health contain an aluminum salt adjuvant or its equivalent (such as aluminum hydroxide, aluminum phosphate, or calcium phosphate) and would benefit from the technology.

Publication date: October 2012

Region: Global

Protecting Child Health for a Promising Future

This fact sheet provides a snapshot of our programs that tackle the leading causes of childhood illness and death: diarrheal disease, pneumonia, and malaria. It profiles our work on new and innovative vaccines, medicines, diagnostics, and devices, as well as cross-cutting approaches that lead to healthy behaviors and lasting improvements to health systems.

Publication date: November 2012

Region: Global

Protecting Children From Diarrheal Disease: PATH Takes a Comprehensive Approach to Combating This Leading Cause of Child Deaths

This fact sheet provides an overview of PATH's work in protecting children from diarrheal disease.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

Protecting Global Access to Lifesaving Vaccines: PATH’s Global Advocacy Strategy During the United Nations Environment Program Mercury Treaty Negotiations

This case study highlights PATH and our partners’ successful advocacy efforts to ensure the protection of vaccines containing thiomersal—a preservative used in multi-dose vaccines. In January 2013, government delegates finalized a global environmental treaty on mercury having agreed to exclude vaccines containing the preservative thiomersal from further regulation.

Publication date: July 2013

Region: Global

Protecting the Promise of Youth: PATH's Adolescent Health Strategic Program

This brochure describes the approach and activities of PATH's adolescent health program.

Author: E.Simpson

Publication date: 2003

Region: Global

Protocol for Evaluating Freezing in the Vaccine Cold Chain

This document is part of a series that describes the serious risk of freezing vaccines and provides tools to reduce freezing in the cold chain. The materials contain current WHO-recommended freeze-prevention strategies targeted toward all levels of storage and transport of vaccines.

Publication date: 2003

Region: Global

Provider Payment Reform and Information Technology Systems: A Chicken and Egg Question for National Health Coverage Programs

This paper addresses key implementation questions raised by countries on the journey toward universal health coverage. It also provides concrete data so that policymakers and information technology (IT) professionals alike may understand the ramifications of the provider payment choice on IT systems.

Author: Wilson K, Latko B, Cashin C, et al.

Publication date: September 2013

Region: Global

Public-Private Partnerships for Global Health: How PATH Advances Technologies Through Cross-Sector Collaboration

This policy report highlights the essential role that public-private partnerships play in driving global health product development and offers insights into the key components of successful multi-sector partnerships led by PATH. For examples of our European public-private partnerships, see Public-Private Partnerships for Global Health: PATH's Collaborations With European Partners.

Publication date: March 2013

Region: Global

Pull Mechanisms for Value-Added Technologies for Vaccines: An Evaluation of the Issues Influencing Vaccine Producer Willingness to Advance, Adopt, and Commercialize Value-Added Technologies for Vaccines for Low-Income and Lower-Middle-Income Country Markets

The Optimize project, a collaboration between PATH and the World Health Organization, commissioned this white paper to examine the issues influencing vaccine producer willingness to advance, adopt, and commercialize value-added technologies for vaccines for low-income and lower-middle-income country markets.

Author: Gilchrist S

Publication date: November 2009

Region: Global

Quantification Tool for Neonatal Resuscitation Devices: Version 1

This national-level quantification tool can be used to develop estimated needs for newborn resuscitation devices. It is designed only to provide estimates of product quantities for planning and cost simulations and is not intended for planning detailed distribution. There are two Excel-based formats of the tool: The enhanced format includes simple design elements, such as graphics and navigation arrows, to guide users through the tool. The standard format retains the cell-based formatting of a traditional Excel file. Both versions contain the same information and formulas and will yield the same data. We invite users to choose the presentation that best meets their needs.

Publication date: February 2014

Region: Global

Quantifying Infectious Waste Produced by HIV/AIDS, Malaria, and Tuberculosis Programs and the Needs for Injection Safety Equipment

This document is intended to start discussions around quantifying the need for safe injection equipment and the amount of infectious sharps waste produced by testing and treatment programs for diseases such as HIV/AIDS, tuberculosis, and malaria. The analysis was developed to support advocacy efforts to integrate injection safety as an essential element of all health care programs.

Publication date: June 2009

Region: Global

Questions Frequently Asked by Women

Publication date: 2003

Region: Global

The Radically Simple Uniject Device

This four-page brochure tells the story of the Uniject device--how it grew from a concept to an easy-to-use, all-in-one injection device that will be used to vaccinate every newborn in Indonesia against hepatitis B and to help eliminate maternal and neonatal tetanus globally. The publication covers the development, evaluation, licensing, production, and design and function of Uniject. Photographs and a timeline of Uniject's history included.

Author: E.Simpson

Publication date: 2003

Region: Global

Rapid Screening Test for Gestational Diabetes

The global diabetes epidemic impacts pregnant women and their babies. This poster describes a rapid, low-cost, non-fasting screening assay proposed by PATH to be used at antenatal care visits. The test would enable interventions to prevent or delay diabetes in the mother and child.

Publication date: July 2012

Region: Global

Rapid Strip Test for Malaria

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for malaria.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

Rapid Tests for Cervical Cancer

Part of the Technology Updates series, this fact sheet describes PATH's work to develop rapid tests for cervical cancer.

Publication date: July 2013

Region: Global

Part of series: Technology Updates

RBP-EIA: A New Approach to Assessing Vitamin A Deficiency

This guide introduces the retinol binding protein enzyme immunoassay (RBP-EIA) to potential advocates and users, and provides information about its prospective role in public health.

Author: Hix J; Levin C; Gorstein J

Publication date: 2003

Region: Global

RBP-EIA: Collecting, Processing, and Handling Venous, Capillary, and Blood Spot Samples (Job Aid)

This document serves as a guide to phlebotomists and a training aid in the proper methods of obtaining blood samples for analysis by the retinol-binding protein enzyme immunoassay (RBP-EIA) used in testing for vitamin A deficiency.

Publication date: 2005

Region: Global

RBP-EIA: Validation and Establishment of a Rapid, Field-Based Tool for the Assessment of Vitamin A Deficiency: A Summary of Available Evidence

This document summarizes available evidence for the validation and establishment of a rapid, field-based tool for the assessment of vitamin A deficiency using the retinol-binding protein immunoassay (RBP-EIA) test.

Publication date: 2006

Region: Global

Re-examining the Role of Cervical Barrier Devices (Outlook, vol. 20, no. 2)

Author: Ellertson C; Burns M

Publication date: February 2003

Region: Global

Part of series: Outlook